Key Financial Data Of Group

JCR Pharmaceuticals Co.,Ltd. - Filing #7710028

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
Key financial data of group
Business results of group
Net sales
22,910,000,000 JPY
23,160,000,000 JPY
20,304,000,000 JPY
20,594,000,000 JPY
17,794,000,000 JPY
18,085,000,000 JPY
17,128,000,000 JPY
17,438,000,000 JPY
16,539,000,000 JPY
16,855,000,000 JPY
Ordinary profit (loss)
5,031,000,000 JPY
5,068,000,000 JPY
3,794,000,000 JPY
3,843,000,000 JPY
2,442,000,000 JPY
2,534,000,000 JPY
2,347,000,000 JPY
2,443,000,000 JPY
2,250,000,000 JPY
2,340,000,000 JPY
Profit (loss) attributable to owners of parent
3,715,000,000 JPY
3,070,000,000 JPY
1,863,000,000 JPY
1,789,000,000 JPY
1,682,000,000 JPY
Comprehensive income
4,008,000,000 JPY
3,016,000,000 JPY
1,831,000,000 JPY
1,557,000,000 JPY
1,936,000,000 JPY
Net assets
30,874,000,000 JPY
30,524,000,000 JPY
27,049,000,000 JPY
27,528,000,000 JPY
27,585,000,000 JPY
27,399,000,000 JPY
27,062,000,000 JPY
26,855,000,000 JPY
26,034,000,000 JPY
26,264,000,000 JPY
Total assets
42,516,000,000 JPY
42,072,000,000 JPY
37,756,000,000 JPY
38,398,000,000 JPY
36,385,000,000 JPY
35,977,000,000 JPY
35,346,000,000 JPY
34,924,000,000 JPY
33,690,000,000 JPY
34,086,000,000 JPY
Net assets per share
982.14
976.96
868.29
877.86
864.66
858.80
843.34
836.87
811.44
818.64
Basic earnings (loss) per share
124.31
120.68
96.97
98.73
59.19
58.95
54.46
56.12
51.72
52.85
Diluted earnings per share
123.56
119.96
96.36
98.11
58.84
58.61
54.15
55.81
51.41
52.53
Equity-to-asset ratio
0.711 xbrli:pure
0.715 xbrli:pure
0.707 xbrli:pure
0.703 xbrli:pure
0.750 xbrli:pure
0.754 xbrli:pure
0.759 xbrli:pure
0.762 xbrli:pure
0.768 xbrli:pure
0.766 xbrli:pure
Rate of return on equity
0.135 xbrli:pure
0.130 xbrli:pure
0.112 xbrli:pure
0.113 xbrli:pure
0.070 xbrli:pure
0.069 xbrli:pure
0.066 xbrli:pure
0.068 xbrli:pure
0.065 xbrli:pure
0.066 xbrli:pure
Price-earnings ratio
52.4 xbrli:pure
54.0 xbrli:pure
62.6 xbrli:pure
61.5 xbrli:pure
41.7 xbrli:pure
41.9 xbrli:pure
47.0 xbrli:pure
45.7 xbrli:pure
48.6 xbrli:pure
47.6 xbrli:pure
Net cash provided by (used in) operating activities
3,905,000,000 JPY
3,133,000,000 JPY
2,651,000,000 JPY
2,201,000,000 JPY
499,000,000 JPY
Net cash provided by (used in) investing activities
240,000,000 JPY
-1,587,000,000 JPY
-841,000,000 JPY
-980,000,000 JPY
-1,419,000,000 JPY
Net cash provided by (used in) financing activities
-917,000,000 JPY
-2,175,000,000 JPY
146,000,000 JPY
-1,314,000,000 JPY
-1,261,000,000 JPY
Cash and cash equivalents
8,091,000,000 JPY
4,850,000,000 JPY
5,464,000,000 JPY
3,523,000,000 JPY
3,643,000,000 JPY
Number of employees
632 xbrli:pure
70 xbrli:pure
543 xbrli:pure
613 xbrli:pure
552 xbrli:pure
xbrli:pure
70 xbrli:pure
10 xbrli:pure
540 xbrli:pure
568 xbrli:pure
566 xbrli:pure
522 xbrli:pure
526 xbrli:pure
482 xbrli:pure
458 xbrli:pure
501 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.